2-methyl-3-hydroxybutyric aciduria
|
phenotype |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
8
|
1
|
0.750 |
definitive |
1.000 |
5 |
1
|
1999 |
2019 |
Intellectual Disability
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1219
|
153
|
0.120 |
None |
1.000 |
2 |
1
|
2008 |
2012 |
Abnormal behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
820
|
101
|
0.110 |
None |
1.000 |
1 |
|
2007 |
2007 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3131
|
968
|
0.100 |
None |
1.000 |
7 |
|
1997 |
2011 |
Mental Retardation, X-Linked
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
128
|
13
|
0.030 |
None |
1.000 |
2 |
|
2007 |
2008 |
Drug Resistant Epilepsy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
182
|
29
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2016 |
Senile Plaques
|
disease |
Pathological Conditions, Signs and Symptoms
|
Acquired Abnormality
|
244
|
21
|
0.020 |
None |
1.000 |
2 |
|
2002 |
2011 |
Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
492
|
59
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2005 |
Metabolic Diseases
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
937
|
50
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2016 |
Neurodegenerative Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
1480
|
85
|
0.020 |
None |
1.000 |
1 |
|
2007 |
2018 |
Dental Plaque
|
phenotype |
Stomatognathic Diseases
|
Disease or Syndrome
|
27
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2694
|
1598
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Channelopathies
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
94
|
8
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Plaque, Amyloid
|
disease |
Pathological Conditions, Signs and Symptoms
|
Acquired Abnormality
|
122
|
10
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Contact Dermatitis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
41
|
3
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2
|
disease |
|
Disease or Syndrome
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Inborn Errors of Metabolism
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome; Congenital Abnormality
|
103
|
3
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Mitochondrial Diseases
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
245
|
17
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6345
|
327
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
nervous system disorder
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
942
|
39
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Osteosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2255
|
155
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Parkinson Disease
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
1952
|
751
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Hyperammonemia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
67
|
5
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |